CYP1B1 and ovarian carcinoma: If true, the interactions between acrylamide and HSD3B SNPs for ovarian cancer [8] and between acrylamide and the CYP1B1 and CYP11A1 SNPs for breast cancer in the current study give some indications that acrylamide may interfere with progesterone metabolism.